title: Merck Advances Oncology Innovation, Highlighting Progress in New Tumor Types and Earlier Stages of Disease at ESMO 2025
source: Yahoo
date: 2025-10-09
url: https://finnhub.io/api/news?id=6e96d0965fe076865fe94b6e0b70829b90a098fac9394239f8d33ccce0446017
RAHWAY, N.J., October 09, 2025--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced new research from more than 100 abstracts across more than 20 types of cancer and multiple treatment settings from the company’s broad and differentiated portfolio and pipeline will be presented at the European Society for Medical Oncology (ESMO) Congress 2025 in Berlin, Germany, from Oct. 17-21. These data showcase Merck’s commitment to rapidly advancing research across multi
